首页> 外文学位 >Preparation and Evaluation of Valacyclovir Hydrochloride Ocular Inserts by Hot Melt Extrusion Technique
【24h】

Preparation and Evaluation of Valacyclovir Hydrochloride Ocular Inserts by Hot Melt Extrusion Technique

机译:热熔挤出技术制备盐酸伐昔洛韦眼药水并评价

获取原文
获取原文并翻译 | 示例

摘要

The objective of the current study was to investigate the processability of Hot Melt Extrusion to formulate Ocular Inserts of Valacyclovir Hydrochloride and Evaluate its drug release in vitro and in vivo. Valacyclovir is the prodrug of Acyclovir, which is used in treatment of ocular keratitis and HSV infections. The bioavailability of the prodrug is better than the acyclovir and it is proved to permeate extensively through the corneal barrier. The polymer of choice was KlucelRTM Pharm MF and JF grades for the study. To optimize the formulation, different physical mixtures of the polymers and plasticizers (PEG 400 and Propylene glycol) were prepared. The physical mixture was extruded through co -- rotating twin-screw Haake MiniLab ThermoFisher RTM Scientific extruder. The obtained ocular inserts were cut into dimensions of 4mmx2mmx1mm to have suitable product instillation in the eye. Ocular inserts were evaluated for drug content, weight variation, uniformity of thickness and in vitro and in vivo drug release. The thermal characterization of ocular inserts was observed using Differential Scanning Calorimetry (DSC). Morphology of the ocular inserts was observed using Scanning Electron Microscopy (SEM). The polymer interactions or incompatibilities was assessed using FTIR. Klucel RTM Pharm MF exhibited desired results than Klucel RTM Pharm JF and was easy to extrude to prepare ocular inserts. The ocular inserts were able to provide sustained drug release compared to eyedrop solution and then dissolve completely in 9 hours.
机译:本研究的目的是研究热熔挤出的加工性能,以配制盐酸伐昔洛韦的眼用插入物,并评估其在体内和体外的药物释放。 Valacyclovir是Acyclovir的前药,用于治疗眼角膜炎和HSV感染。前药的生物利用度优于阿昔洛韦,并被证明可广泛渗透通过角膜屏障。本研究选择的聚合物为KlucelRTM Pharm MF和JF级。为了优化配方,制备了聚合物和增塑剂(PEG 400和丙二醇)的不同物理混合物。通过共同旋转的双螺杆Haake MiniLab ThermoFisher RTM Scientific挤出机挤出物理混合物。将获得的眼用插入物切成4mmx2mmx1mm的尺寸,以便在眼睛中滴入合适的产品。评估了眼插入物的药物含量,重量变化,厚度均匀性以及体外和体内药物释放。使用差示扫描量热法(DSC)观察了眼插入物的热特性。使用扫描电子显微镜(SEM)观察眼插入物的形态。使用FTIR评估聚合物的相互作用或不相容性。与Klucel RTM Pharm JF相比,Klucel RTM Pharm MF表现出所需的结果,并且易于挤出以制备眼用插入物。与滴眼剂溶液相比,眼用插入物能够提供持续的药物释放,然后在9小时内完全溶解。

著录项

  • 作者

    Shadambikar, Gauri.;

  • 作者单位

    The University of Mississippi.;

  • 授予单位 The University of Mississippi.;
  • 学科 Pharmaceutical sciences.
  • 学位 M.S.
  • 年度 2018
  • 页码 56 p.
  • 总页数 56
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号